Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$3.12K Hold
88
﹤0.01% 2140
2024
Q4
$3.07K Sell
88
-336
-79% -$11.8K ﹤0.01% 2169
2024
Q3
$16.4K Sell
424
-198
-32% -$7.28K ﹤0.01% 1399
2024
Q2
$22K Buy
622
+415
+200% +$13.4K ﹤0.01% 1193
2024
Q1
$6.86K Buy
207
+167
+418% +$6.22K ﹤0.01% 1757
2023
Q4
$1.75K Sell
40
-4
-9% -$160 ﹤0.01% 2306
2023
Q3
$2.02K Sell
44
-15
-25% -$679 ﹤0.01% 2126
2023
Q2
$2.94K Buy
59
+3
+5% +$145 ﹤0.01% 2011
2023
Q1
$3K Sell
56
-111
-66% -$6.05K ﹤0.01% 2076
2022
Q4
$11.4K Buy
167
+39
+30% +$2.62K ﹤0.01% 1375
2022
Q3
$8K Buy
128
+122
+2,033% +$6.52K ﹤0.01% 1407
2022
Q2
$0 Buy
+6
New +$223 ﹤0.01% 2509

Other funds holding CALX

Lindbrook Capital's CALX Position: Q1 2025 in Review

Lindbrook Capital held its Calix (CALX) position steady in Q1 2025 at 88 shares worth $3.12K. The position accounts for ﹤0.01% of the portfolio, ranked #2140.

Lindbrook Capital first reported a position in CALX in Q2 2022 and has held it in 12 quarters since. The position peaked at $22K in Q2 2024. 260 funds tracked by Wall St. Rank hold CALX as of Q1 2025.

  • Lindbrook Capital held 88 shares of Calix worth $3.12K as of Q1 2025.
  • Lindbrook Capital left its Calix share count unchanged in Q1 2025.
  • Calix made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2140 holding.
  • Lindbrook Capital first reported a position in Calix in Q2 2022 and has held it in 12 quarters since.
  • Lindbrook Capital's Calix position peaked at $22K in Q2 2024.
  • 260 funds tracked by Wall St. Rank held Calix as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.